May 15, 2017

Pembrolizumab Combination Granted Accelerated Approval for Non-Small Cell Lung Cancer 

Pembrolizumab (Keytruda) was granted accelerated approval by the FDA in combination with pemetrexed and carboplatin to treat patients with previously untreated metastatic non-squamous non-small cell lung […]
April 27, 2016

The Changing Face of Liver Cancer

Hepatitis C infections get a lot of bad press when it comes to liver cancer. While it is true that hepatitis C is a significant risk […]
March 22, 2016

Turning the Body into a Cancer-Fighting Machine

  Kimberly M. Hicks, Pharm.D., M.H.A., Clinical Pharmacy Specialist at BioPlus Specialty Pharmacy The body’s immune system possesses all the tools it needs to kill cancer […]
January 25, 2016

Cost and Value 

Dr. Stephen Vogt’s BioBlog Where does the true value of cancer treatment lie? Oncology experts grapple with this important question, with one of the more recent […]
January 14, 2016

Who Isn’t Taking Their Cancer Medication?

Just a few years ago, a physician knew immediately if a patient didn’t follow the prescribed cancer treatment, because the treatment was likely given intravenously at […]
January 14, 2016

Coping with ‘Financial Toxicity’

Multiple myeloma, a type of cancer affecting the bone marrow, will be diagnosed in an estimated 27,000 Americans this year. Advances in research are expanding treatment […]
January 14, 2016

When Price Stands in the Way

Medication non-adherence can be traced back to numerous causes. For some patients, the side effects of a given medication become too burdensome. Sometimes it is simple […]